[Other] Optimal component replacement decisions using vibration monitoring and the proportional-hazards model |
|
This post will be closed automatically in 2026-10-30 04:42
Best Answer
1 hour(s) ago
|
| |
10
Immunotherapy with nivolumab in NSCLC: single center experience after one year clinical practice
300
Development of loop-mediated isothermal amplification (LAMP) assay combined with FTA card for testing Babesia microti
20
Tivozanib combined with nivolumab: Phase Ib/II study in metastatic renal cell carcinoma (mRCC).
20
Avelumab in patients with previously treated mesothelioma: Updated phase 1b results from the JAVELIN Solid Tumor trial.
20
Epacadostat plus nivolumab for advanced melanoma: Updated phase 2 results of the ECHO-204 study.
